BUND FINANCE › Stocks › DHR
Danaher Corporation (DHR)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +2.26% above its 50-day average.
- It is +13.60% above its 200-day average (long-term uptrend).
- It sits at 82% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | US$29.5B | US$26.6B | US$23.9B | US$23.9B | US$24.6B |
| Net income | US$6.4B | US$7.2B | US$4.8B | US$3.9B | US$3.6B |
| EPS (diluted) | 8.61 | 9.64 | 6.38 | 5.29 | 5.05 |
| Gross margin | 61.0% | 60.8% | 58.7% | 59.5% | 60.9% |
| Operating margin | 25.4% | 28.3% | 21.8% | 20.4% | 19.1% |
| Net margin | 21.8% | 27.1% | 19.9% | 16.3% | 14.7% |
| Free cash flow | US$7.1B | US$7.4B | US$5.8B | US$5.3B | US$5.3B |
| Total debt | US$23.3B | US$20.6B | US$19.5B | US$17.1B | US$18.4B |
| Cash | US$2.6B | US$6.0B | US$5.9B | US$2.1B | US$4.6B |
Compound annual growth: revenue -4.4% · net income -13.4% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 37.4x | 36.3x | 27.1x |
| EV / EBITDA | 25.6x | 23.5x | 16.5x |
| Operating margin | 20.4% | — | 3.6% |
| Net margin | 16.9% | — | -0.0% |
| Debt / equity | 0.74 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongs…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice